EAGER: Engineered nano-scale barrier to prevent viral infections

  • Funded by National Science Foundation (NSF)
  • Total publications:1 publications

Grant number: 2029677

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $299,999
  • Funder

    National Science Foundation (NSF)
  • Principal Investigator

    Mark Humayun
  • Research Location

    United States of America
  • Lead Research Institution

    University of Southern California
  • Research Priority Alignment

    N/A
  • Research Category

    Infection prevention and control

  • Research Subcategory

    Barriers, PPE, environmental, animal and vector control measures

  • Special Interest Tags

    Innovation

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Engineering - This project proposes to use in silico simulations to engineer nanoscale, biocompatible, protective barrier that will enhance our first line of defenses - prevention of pathogenic infection from entering and infecting the host. The principal investigator aims to develop a topical method that will enhance protection against virus attachment onto the nasal and oral as well as conjunctival epithelial cells, while preserving normal physiology and biochemistry. The project team will use computer models to engineer delivery devices to produce the optimal particle characteristics to maximally prevent microbial infection. If successful, this project can lead to paradigm changing alternatives to reducing public health risk to air borne infections like COVID-19 and seasonal flu which may be associated with devastating effects on the United States and World economy. The proposed approach will be swiftly conducted to present realistic solutions that may be useable in the face of this COVID-19 pandemic as well as future flu viruses of similar magnitude.

This research will fundamentally contribute to modeling the interactions between viral membranes and nanoscale barriers. The production of an innovative nanoscale biodegradable barrier may reduce the socioeconomic and public health burden significantly by lowering the risk of viral infection during the flu season or pandemics. The project team comprise of an interdisciplinary team that include engineers, ophthalmologists, molecular biologist, virologist and pharmacologist to explore a problem that could have a tremendous impact on the way we respond to seasonal flu or pandemics. Besides the potential benefits to reduce COVID-19 and influenza related deaths in the US and worldwide, the proposed work will afford us the opportunity to train engineering and biomedical students in a highly interdisciplinary research activity.

This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

Publicationslinked via Europe PMC

Last Updated:14 hours ago

View all publications at Europe PMC

Hydroxypropyl-Beta Cyclodextrin Barrier Prevents Respiratory Viral Infections: A Preclinical Study.